Evidence map›Paper›PMID 37511605›Full record

ArticleInternational journal of molecular sciences2023

Transient Receptor Potential Ankyrin 1 (TRPA1) Channel Mediates Acrolein Cytotoxicity in Human Lung Cancer Cells.

Akihiko Sakamoto, Yusuke Terui, Kazuei Igarashi, Keiko Kashiwagi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. The role of TRPA1 in lung cancer.Translational lung cancer research · 2025
    Review
  2. Article
  3. Article
  4. Special Issue "Polyamines in Aging and Disease".International journal of molecular sciences · 2024
    Article
  5. Spermidine Synthase Localization in Retinal Layers: Early Age Changes.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Akihiko SakamotoFaculty of Pharmacy, Chiba Institute of Science, Choshi 288-0025, Japan.ORCID 0000-0002-1447-4691
Yusuke TeruiFaculty of Pharmacy, Chiba Institute of Science, Choshi 288-0025, Japan.ORCID 0000-0003-0670-321X
Kazuei IgarashiAmine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba 260-0856, Japan.
Keiko KashiwagiFaculty of Pharmacy, Chiba Institute of Science, Choshi 288-0025, Japan.
Chiba Institute of Science · JPChiba University · JP

Funding

Japan Society for the Promotion of Science 21K06714Japan Society for the Promotion of Science 21K15258Smoking Research Foundation 2018Y009
6 · The paper itself

Abstract

Transient receptor potential ankyrin 1 (TRPA1) is a nonselective ion channel implicated in thermosensation and inflammatory pain. It has been reported that expression of the TRPA1 channel is induced by cigarette smoke extract. Acrolein found in cigarette smoke is highly toxic and known as an agonist of the TRPA1 channel. However, the role of TRPA1 in the cytotoxicity of acrolein remains unclear. Here, we investigated whether the TRPA1 channel is involved in the cytotoxicity of acrolein in human lung cancer A549 cells. The IC

Indexed as

Lung NeoplasmsTransient Receptor Potential ChannelsAcroleinAnkyrinsCytoskeletal ProteinsHumansTRPA1 Cation ChannelAcroleinAnkyrinsCytoskeletal ProteinsTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPA1 protein, humanacroleincell damagecytotoxicitytransient receptor potential ankyrin 1 (TRPA1)

Identifiers

PMID37511605
PMCPMC10380761
OpenAlexW4385241854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.